Valneva SE (VALN)
NASDAQ: VALN
· Real-Time Price · USD
5.82
0.07 (1.22%)
At close: Jun 27, 2025, 3:59 PM
5.80
-0.34%
After-hours: Jun 27, 2025, 04:00 PM EDT
1.22% (1D)
Bid | 5.26 |
Market Cap | 494.89M |
Revenue (ttm) | 186.06M |
Net Income (ttm) | -80.39M |
EPS (ttm) | -1.29 |
PE Ratio (ttm) | -4.51 |
Forward PE | -9.71 |
Analyst | Buy |
Ask | 6.98 |
Volume | 25,036 |
Avg. Volume (20D) | 75,885 |
Open | 5.64 |
Previous Close | 5.75 |
Day's Range | 5.64 - 5.97 |
52-Week Range | 3.62 - 8.66 |
Beta | 1.09 |
About VALN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VALN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VALN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Valneva SE is scheduled to release its earnings on Aug 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+12.08%
Valneva shares are trading higher after the Brazil...
Unlock content with
Pro Subscription
3 months ago
+3.63%
Valneva shares are trading higher after reaching an agreement with a local French public health agency to provide 40,000 doses of IXCHIQ.

1 month ago · seekingalpha.com
Valneva SE: Still Undervalued Travel Vaccine Bet With Robust 2025 GuidanceValneva SE offers exposure to a robust travel vaccine portfolio that includes Ixiaro, Dukoral, and Ixchiq. Ixiaro generated roughly €94.1 million in 2024 and remains Valneva's main revenue vertical. D...

2 months ago · accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SE - VALNNEW YORK CITY, NY / ACCESS Newswire / April 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Valneva SE ("Valneva" or the "Company") (NASDAQ:VALN). Such investors are advised...